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Abstract
Background
Lymphatic filariasis and onchocerciasis are disabling and disfiguring neglected tropical
diseases of major importance in developing countries. Ivermectin is the drug of choice
for mass drug administration programs for the control of onchocerciasis and lymphatic fil-
ariasis in areas where the diseases are co-endemic. Although ivermectin paralyzes
somatic and pharyngeal muscles in many nematodes, these actions are poorly charac-
terized in adult filariae. We hypothesize that paralysis of pharyngeal pumping by iver-
mectin in filariae could result in deprivation of essential nutrients, especially iron,
inducing a wide range of responses evidenced by altered gene expression, changes in
metabolic pathways, and altered developmental states in embryos. Previous studies
have shown that ivermectin treatment significantly reduces microfilariae release from
females within four days of exposure in vivo, while not markedly affecting adult worms.
However, the mechanisms responsible for reduced production of microfilariae are poorly
understood.
Methodology/Principal Findings
We analyzed transcriptomic profiles from Brugia malayi adult females, an important model
for other filariae, using RNAseq technology after exposure in culture to ivermectin at various
concentrations (100 nM, 300 nM and 1 μM) and time points (24, 48, 72 h, and 5 days). Our
analysis revealed drug-related changes in expression of genes involved in meiosis, as well
as oxidative phosphorylation, which were significantly down-regulated as early as 24 h
post-exposure. RNA interference phenotypes of the orthologs of these down-regulated
genes in C. elegans include “maternal sterile”, “embryonic lethal”, “larval arrest”, “larval
lethal” and “sick”.
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Conclusion/Significance
These changes provide insight into the mechanisms involved in ivermectin-induced reduc-
tion in microfilaria output and impaired fertility, embryogenesis, and larval development.
Author Summary
Lymphatic filariasis and onchocerciasis are tropical diseases caused by infections with par-
asitic nematodes. Resulting chronic diseases can be strongly blinding and disfiguring, and
contribute to an entrenched cycle of poverty in affected populations. Ivermectin is one of
the pivotal drugs used to control these infections. The mechanism of antifilarial action of
the drug is incompletely resolved. It kills circulating larval stages (microfilariae), but only
reversibly sterilizes adult worms without killing them. Our limited understanding of the
involved mechanisms hampers treatment optimization and sustainability of the efficacy of
the drug, and investigations into its pharmacology are of paramount importance. Working
with Brugia malayi adult females, we employed RNA sequencing and bioinformatics anal-
yses to identify genes for which expression levels changed as a result of exposure to the
drug in vitro. Ivermectin exposure altered the expression of genes that are likely to func-
tion in the B.malayi female reproductive system even at the lowest concentration tested.
Through several biological pathways, genes involved in meiosis were particularly affected.
These findings provide some insight into the mechanisms involved in ivermectin-induced
reduction in microfilaria output and impaired fertility, embryogenesis, and larval
development.
Introduction
Lymphatic filariasis (LF) is caused by the transmission ofWuchereria bancrofti, Brugia malayi,
and Brugia timori by infected mosquitos and is endemic in 60 countries, mainly in subtropical
and tropical regions, with over 120 million people infected [1]. Onchocerciasis (river blindness)
is caused by Onchocerca volvulus and afflicts 25 million people in 24 countries, mainly in Sub-
Saharan Africa [2]. Long-running control and elimination programs aim to reduce transmis-
sion of both infections by mass drug administration (MDA) of microfilaricidal drugs and to
alleviate suffering and disability in onchocerciasis patients [3, 4].
The macrocyclic lactones (ML) are a class of broad-spectrum anthelmintic drugs which
include the avermectins and milbemycins (e.g., ivermectin (IVM) and moxidectin, respec-
tively) [5]. Although similar in structure, they differ in pharmacokinetics and dynamics as well
as physicochemical properties [6, 7]. These drugs have been extensively used in veterinary
medicine for the treatment or prevention of nematode infections and ectoparasite infestations.
In human medicine, IVM is one of the three mainstay drugs in the LF global elimination pro-
gram [8] and is the only drug used in onchocerciasis MDA campaigns [2]. IVM is predomi-
nantly microfilaricidal, the killing effect on adults being only moderate and requiring repeated
treatment cycles over several years [9].
IVM pseudo-irreversibly activates nematode and arthropod glutamate-gated chloride chan-
nels (GluCls), resulting in hyperpolarization of neurons and pharyngeal muscle cells, leading
to paralysis of movement and pharyngeal pumping, and ultimately starvation of the worm
[10–12]. Treatment results in a dramatic reduction in microfilaria (mf; first-stage larvae (L1)
production by adult female filariae, but the mechanisms involved are not understood. GluCl
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expression in B.malayimf was localized to a muscle structure surrounding the excretory-secre-
tory (ES) vesicle, suggesting that release of proteins was regulated by GluCls (14). In the same
study, IVM exposure resulted in a significant reduction of protein release, possibly preventing
the secretion of proteins that allow evasion of the host’s immune system [13]. Recently, the B.
malayi GluCl gene avr-14 was found to be highly expressed in reproductive tissues and
embryos, suggesting an involvement of GluCls in gamete production and embryogenesis which
may account for the sterilizing effect observed in adult filarial worms treated with IVM [14].
Our limited understanding of IVM’s mode of action on adult filarial worms hampers treatment
optimization and sustainability of the efficacy of this drug, and investigations into its pharma-
cology are of paramount importance.
We used adult female B.malayi, a well-characterized model of filarial infections, to study
the time-dependent transcriptomic changes induced by exposure to IVM in vitro. We per-
formed two separate studies: 100 nM IVM exposure for up to 72 h, and 300 nM and 1 μM for
up to 5 days, to gain insight into the mechanisms which underlie the drug-induced long-term
sterility of adult females and subsequent reduction of mf in skin or blood of treated patients.
The drug concentrations used in this present study have previously been tested on adult B.
malayi females in vitro [15] and have also been tested in C. elegans [7]. The rationale for using
the lowest concentration (100 nM) in the first study was to expose worms to a concentration
similar to plasma levels detected in humans after administration of a dose typically used in
MDA [16–18]. It is recommended that in vitro experimental analyses of drug effects include
concentrations higher than the maximal blood/plasma concentration achieved in an animal
[19]. We therefore tested higher IVM concentrations in a second phase. These results allowed
us to also compare our results with those previously observed in B.malayi at these
concentrations.
Materials and Methods
Ethics statement
All animal procedures were approved by the University of Georgia, Institutional Animal Care
and Use Committee, and complied with U.S. Department of Agriculture's regulations (USDA
Assurance No. A3437-01)
Parasites and study designs
Adult male jirds (Meriones unguiculatus) were infected subcutaneously with400 infective B.
malayi larvae (L3). After a minimum of 90 days post-infection (ranging from 3 to 6 months),
jirds were euthanized by exposure to CO2 and adult worms were collected from the peritoneal
cavity via lavage.
Study design
First study. Female worms from three individual jird hosts were randomly assigned to 15
groups (9 untreated and 6 exposed to 100 nM IVM) of 10 worms each. The study design con-
sisted of 4 time points (before drug exposure, 24, 48, and 72 h). Three technical replicates were
used before drug exposure and duplicates for the remaining conditions (Fig 1).
Second study. Female worms from three individual jird hosts were randomly assigned to
21 groups (9 untreated, 6 exposed to 300 nM IVM, and 6 exposed to 1 μM IVM) of 10 worms
each. The study design consisted of 3 time points (before drug exposure, 48 h and 5 d). Three
technical replicates were used for each condition (Fig 1).
Transcriptome of Ivermectin-Treated Brugia malayi
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For both studies, worms were collected from jirds at the NIH-NIAID Filariasis Research
Reagent Resource Center (FR3) at the University of Georgia and separated by sex. Worms were
then shipped overnight in separate tubes of 15 ml culture media containing RPMI-1640 (Bio-
Whittaker Classic Cell Culture Media, Lonza Walkersville Inc.) and 1% v/v gentamycin (genta-
mycin solution, 10 mg/ml Sigma Aldrich Inc.) to McGill University for further analysis. The
separate studies were conducted several months apart.
Upon arrival at McGill, the first group (before drug exposure) was thoroughly washed sev-
eral times in PBS and flash-frozen in liquid N2 for RNA extraction.
Remaining worms were incubated 1 worm per well of a 6-well plate (Costar) containing 6
ml RPMI 1640 (Sigma-Aldrich) supplemented with 10% v/v heat-inactivated fetal bovine
serum (Sigma-Aldrich, F1051), 5% penicillin/streptomycin (Sigma–Aldrich P4333) and 2% v/v
gentamycin (Gibco, 15750–060). Worms were cultured for another 24, 48, or 72 h (first study)
and 48 h or 5 days (second study) at 37°C, 5% CO2 with or without exposure to IVM (Sigma-
Aldrich I8898) at 100 nM (study 1), 300 nM or 1 μM (study 2). Control wells contained 0.1%
v/v DMSO. On a daily basis, 3 ml of culture media (with or without drug at the different con-
centrations) in each well was replaced with fresh media.
RNA extraction
RNA extraction was performed as described previously [20]. Briefly, live worms were washed
several times with PBS; immotile worms were excluded from the study. RNA was extracted
from 5 to 8 worms per group using nuclease-free reagents. On ice, 125 μl 0.1X Tris-EDTA (TE)
Fig 1. Study design. At each time point, two or three groups of 10 worms were washed, flash-frozen (represented by
lightning bolt) and used for RNA extraction. IVM: ivermectin.
doi:10.1371/journal.pntd.0004929.g001
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buffer, pH 8.0 (Ambion, Life Technologies, Burlington, ON) and 375 μl Trizol LS reagent
(Ambion) were added to each tube. Worm extracts were obtained by conducting three cycles
of flash-freezing in liquid N2 followed by crushing of worms using plastic pestles. One-hundred
(100) μl chloroform was added to each sample in a 1.5 ml Eppendorf tube, which was vortexed
and incubated 3 min at room temperature. The extracts were transferred to phase-lock gel
heavy tubes (5 PRIME, Gaithersburg, MD) and centrifuged at 11,900 x g at 4°C for 15 min for
phase separation. The aqueous phase (approximately 150 μl) was transferred to fresh 1.5 ml
Eppendorf tubes and mixed with 250 μl ice-cold isopropanol. RNA was precipitated by centri-
fugation at 12,200 x g at 4°C for 30 min followed by an overnight incubation at -20°C. Pellets
were washed twice with 80% EtOH, allowed to dry and resuspended in 50 μl 0.1X TE prior to
heating at 55°C for 10 min. Total RNA was purified and concentrated on columns (RNeasy
Min-Elute Cleanup Kit, Qiagen, Valencia, CA). Samples were treated with DNase (Ambion
DNA-free Kit, Life Technologies, AM1906, Burlington, ON) according to the manufacturer’s
instructions to remove contaminating DNA. Assessment of RNA concentration and purity was
done by spectrophotometry (NanoDrop 1000, Wilmington, DE) and RNA samples were
shipped overnight on dry ice to the NIH-FR3 (Molecular Division) at Smith College (North-
ampton, MA) for cDNA library preparation and Illumina sequencing. RNA concentration,
purity and integrity were precisely measured using the Qubit RNA BR Assay Kit (Life Technol-
ogies, Q10210, Burlington, ON) and on an Agilent 2100 Bioanalyzer (Santa Clara, CA).
cDNA library preparation and Illumina sequencing
Messenger RNA was isolated with a NEBNext Poly (A) mRNAMagnetic Isolation Module
(New England Biolabs, E7490). The enriched mRNA served as template for cDNA library
preparation with a NEBNext Ultra RNA Library Prep Kit Illumina (NEB, E7530) and NEBNext
Multiplex Oligos for Illumina (Index Primer 1–12) (NEB, E7600) following the manufacturer’s
instructions. Assessment of quality, concentration and size of the cDNA, was performed for
each library using a Qubit 2.0 Fluorometer (Life Technologies, Q32866), Qubit dsDNA BR
assay kit (Life Technologies, Q32850), High Sensitivity DNA Analysis Kit (Agilent, 5067–
4626) and Agilent 2100 Bioanalyzer. cDNA libraries were sequenced on an Illumina MiSeq
Platform employing a 150 base pair paired-end NGS setting. Sequencing data were uploaded
and stored in BaseSpace (https://basespace.illumina.com) for subsequent analysis.
Data analysis
RNA sequencing analysis
Procedures for data analysis were previously described [20]. Unaligned raw sequencing data
(fastq) files were downloaded to the Mason-Galaxy platform hosted at Indiana University
(http://galaxy.iu.edu/) [21, 22]. Raw sequence data were first processed using Fastq Groomer
(v 1.0.4) to convert file format to Fastq Sanger format and quality scores were verified using
FastQC (version 0.52). Based on quality statistics, sequences were trimmed from both the 5’
and 3’ ends using Fastq Quality Trimmer (v 1.0.0) and Trim Galore (v 0.2.8.1). Mapping of
gapped reads to the B.malayi reference genome (ftp://ftp.wormbase.org/pub/wormbase/
species/b_malayi/sequence/genomic/b_malayi.PRJNA10729.WS243.genomic.fa.gz) was per-
formed with Tophat2 (v 0.6) and RNA sequencing metrics were retrieved using Picard tools
(Table 1). Picard alignment summary metrics (http://broadinstitute.github.io/picard/) were
generated from BAM files using SAM/BAM Alignment Summary Metrics (version 1.56.0) tool.
The read count table was then generated by counting the number of reads per gene feature
with HTSeq-count (version 1.0.0) [23] using the union mode to handle reads covering more
than one feature and default settings for all other parameters. Differential gene expression
Transcriptome of Ivermectin-Treated Brugia malayi
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analysis between time points and drug concentrations was realized in edgeR (version 3.10.5)
[24] through the web interface provided by NetworkAnalyst (http://networkanalyst.ca) [25,
26]. To correct for different library sizes and reduce RNA compositional effects, read counts
for gene features were normalized in edgeR using the trimmed mean of M-values (TMM)
method [27]. The empirical Bayes method based on weighted conditional maximum likelihood
was employed to estimate tagwise (gene-specific) dispersion values [28]. Once negative bino-
mial models were fitted and dispersion values estimated, the exact test was used for pairwise
differential expression testing between treated and untreated groups. Significance was set as an
experiment-wide false discovery rate (FDR)<0.20 (after the Benjamini-Hochberg method
[29]). After filtering, gene lists for each pairwise comparison were imported into Microsoft
Excel for further analysis.
Common dispersion, which provides information on the overall variability across the
genome for a dataset, and Biological Coefficients of Variation (BCV) were calculated; BCV
plots were generated using the edgeR Bioconductor package (version 3.12.0) [24].
Bioinformatics analysis of the sequence data. From lists of retained genes for each com-
parison, the Wormbase Gene ID was used to retrieve the primary corresponding sequence ID
of the gene fromWormbase (http://www.wormbase.org/) and the UniProt accession number
[30]. Protein coding sequences fromWormbase were used in BLASTn in order to find the clos-
est B.malayi gene hit and attribute a GenBank ID and annotation to each gene. Gene Ontology
(GO) terms [31] were obtained when available from nematode.net (v 4.0; http://nematode.net/
NN3_frontpage.cgi) [32, 33]. Enriched GO terms and KEGG/Panther pathways were retrieved
and analyzed using WebGestalt (WEB-based Gene SeT AnaLysis Toolkit) [34]. Pathways and
GO terms were considered significantly enriched when FDR<0.05. Since many DE genes
detected in this study were uncharacterized or not annotated yet had orthologs which could be
identified in the Caenorhabditis elegans genome, we used the Uniprot accession numbers of
the C. elegans orthologs of B.malayi differentially expressed (DE) genes for enrichment analy-
sis, accepting hits with a minimal E-value of 110−20 and using the Blast-based Reciprocal Best
Hit (RBH) strategy for identifying orthologs [35, 36]. RNA interference (RNAi) phenotypes
associated with the C. elegans orthologs of down-regulated genes at 48 h with 100 nM IVM
exposure involved in reproduction, embryo and larval development were retrieved from www.
wormbase.org. A hypergeometric test was performed to determine which phenotypes in this
dataset were significantly enriched when compared with their overall occurrence in the C.
Table 1. Picard alignment summarymetrics. Summary of the sequencing and mapping of the data to the B.malayi transcriptome.
Time
point
Concentration Total #
Transcripts
Ave Total #
Reads
Ave Total # Reads
Mapped
Ave Total # High Quality
Reads Mapped
% High Quality Reads
Mapped
Study
1
24 h IVM (100 nM) 10691 3537601 3537500 2990362 84.53
Control 10511 2765626 2765551 2364245 85.49
48 h IVM (100 nM) 10086 2513891 2513834 2145661 85.35
Control 10214 2957918 2957831 2519799 85.19
72 h IVM (100 nM) 10705 3875640 3874592 3380930 87.24
Control 10428 3081545 3081499 2683543 87.09
Study
2
48 h IVM (300 nM) 10087 2091222 2091198 1710598 81.80
IVM (1 μM) 10177 2212133 2212085 1757015 79.43
Control 10328 2808908 2808880 2325764 82.80
5 d IVM (300 nM) 9959 1799180 1799161 1456538 80.96
IVM (1 μM) 9837 1798183 1798159 1426230 79.32
Control 10250 2464701 2464671 2017612 81.86
doi:10.1371/journal.pntd.0004929.t001
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elegans RNAi dataset. P-values were corrected for multiple testing using the Benjamini-Hoch-
berg method (1995) with a level of significance of q<0.05.
Results
Sequencing and mapping
Table 1 displays the total number of transcripts obtained for each sample in both studies and
the number of sequence reads for each cDNA library. On average for study 1 (100 nM IVM),
85.82% of the high quality sequence reads were mapped to the B.malayi transcriptome after
removal of ambiguous sequence matches (Table 1). Gene mapping fluctuated from 1 to 58487
sequence read(s) per gene. On average for study 2 (300 nM and 1 μM IVM), 81.03% of the high
quality sequence reads were mapped to the B.malayi transcriptome after removal of ambigu-
ous sequence matches, and gene mapping fluctuated from 1 to 27507 sequence read(s) per
gene (Table 1). In study 1, 93.28–95.79% of reads aligned in pairs to a transcript; in study 2,
90.43–93.52% of reads aligned in pairs.
BCV values ranged from 17 to 27% in the first study and 15 to 35% in the second study (S3
Table). BCV plots show that the BCV values in the first study tended to increase over time and
are shown in S1A–S1C Fig. In the second study, the BCV values were higher at the 48 h time
point than at 5 days for both IVM concentrations.
We used gene expression levels from untreated (control) worms at each time point as a
baseline to identify genes with differential expression after exposure to IVM in each sample.
Pairwise comparisons revealed 15 (100 nM, 72 h) to 421 (100 nM, 48 h) DE genes (Table 2, S1
Table). Between 20.59 and 65.15% of DE genes could be assigned GO terms, while similar pro-
portions had a C. elegans ortholog.
Transcriptomic profiles of worms exposed to IVM
The greatest overlap of DE genes was seen between the 300 nM and 1 μM groups, with 66 dys-
regulated genes. When comparing the overlap of DE genes from the first and second study,
only 5 genes were found to overlap across the 3 concentrations, with 10 genes in common
between the 100 nM and 300 nM groups and 20 genes in common between the 100 nM and
1 μM groups. GO term enrichment showed that 5 of these genes were enriched in “structural
molecule activity”molecular function (GO:0005198; FDR = 0.009). Five genes were common
to all three IVM treatments (Bm8439 and Bm4605 (two collagens), Bm9776, Bm6450, and
Bm9380). Bm9380 is a serpin precursor (Bm-spn-2) and was significantly up-regulated in both
studies (100 nM 72 h; 300 nM and 1 μM 5 days; log2 fold-changes 1.37–2.57). Bm9776 encodes
a hypothetical protein and was also significantly up-regulated at four time points between both
studies (log2 fold-changes 1.06–1.85). Lastly, Bm6450 is annotated as a GTPase activating
Table 2. Numbers of differentially expressed genes over time after IVM exposure in culture.
100 nM IVM 300 nM IVM 1 μM IVM
24 h 48 h 72 h 48 h 5 d 48 h 5 d
Total DE genes 34 421 15 132 68 147 271
Total DE genes up-regulated 21 141 2 14 24 136 74
Total DE genes down-regulated 13 280 13 118 44 11 197
Sequences with GO terms* 7 178 9 86 29 49 160
Sequences with C. elegans ortholog 7 257 9 92 37 64 186
*GO terms were provided by Nematode.net V.4 [33]. IVM: ivermectin; DE: differentially expressed
doi:10.1371/journal.pntd.0004929.t002
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protein for Arf containing protein and was found to be down-regulated across three different
time points between both studies (log2 fold-changes -1.06 to -1.43).
Study 1: Transcriptomic profiles of worms exposed to 100 nM IVM. At 100 nM IVM,
460 DE genes were identified across all time points. Worms exposed to 100 nM IVM for up to
72 h showed the largest change in their transcriptome profiles at 48 h post-exposure (421 DE
genes), at which time 67% of those genes were down-regulated (S1 Table, Table 2). Among
them, a dynein light chain type 1 family protein, Bm8648, was down-regulated (log2 fold-
change: -1.46), as well as Bm14080 (log2 fold-change: -1.51). A cytidine deaminase (Bm4230)
was the gene most down-regulated at the 48 h and 72 h time points (log2 fold-change: -5.21
and -6.90, respectively), while the most prominently up-regulated gene in study 1 was Bm8966
(hypothetical protein; log2 fold-change: 6.91; 72 h 100 nM). To cite only a few interesting dys-
regulated genes at 48 h or 72 h, Bma-nep-1, a neprilysin (Bm7419, log2 fold-change: -3.92), 6
enzymes involved in oxidative phosphorylation (Bm6047, Bm3783, Bm3758, Bm5403,
Bm10539, Bm2497; log2 fold-changes between -0.85 and -1.53), and inositol-1 (Bm11145; log2
fold-change: -4.48) were among down-regulated genes. Eight DE genes overlapped across the
24 h and 48 h time points (among them, a kinesin light chain protein 2 (Bm9032), up-regulated
at 24 h (log2 fold-change: 2.10) but then significantly down-regulated by 72 h (-3.23 log2 fold-
change); only one common DE gene was found at both 48 h and 72 h. One DE gene was shared
between 24 h and 72 h (but not with 48 h).
Exposure to 100 nM also resulted in the significant down-regulation (-1.16 to -2.83 log2
fold) of five cuticle collagens at all time points.
Gene Ontology enrichment analysis of the 100 nM (48 h) dataset revealed significant
enrichment of genes with GO terms associated with “growth” (GO:0040007; FDR = 2.03e-08),
“locomotion” (GO:0040011; FDR = 2.99e-07) and developmental processes which included
“embryo development” (GO:0009790; FDR = 1.07e-06), “embryo development ending in birth
or egg hatching” (GO:0009792; FDR = 1.07e-06) and “nematode larval development”
(GO:0002119; FDR = 1.07e-06), with 63–91 genes enriched in these categories. Table 3 shows
Table 3. Gene Ontology enrichment analysis of top 15 biological processes at 100 nM IVM exposure for 48 h.
Gene Ontology Term* GO Identity Observed Expected Reference Ratio of Enrichment FDR value**
growth GO :0040007 85 45.16 2498 1.88 2.03E-08
locomotion GO :0040011 63 30.10 1665 2.09 2.99E-07
embryo development GO :0009790 91 55.49 3069 1.64 1.07E-06
embryo development ending in birth or egg hatching GO :0009792 89 54.10 2992 1.65 1.07E-06
nematode larval development GO :0002119 72 39.00 2157 1.85 1.07E-06
larval development GO :0002164 72 39.03 2159 1.84 1.07E-06
post-embryonic development GO :0009791 72 39.31 2174 1.83 1.07E-06
establishment of localization GO :0051234 65 33.63 1860 1.93 1.07E-06
transport GO :0006810 63 32.33 1788 1.95 1.21E-06
regulation of growth GO :0040008 61 31.24 1728 1.95 1.96E-06
positive regulation of growth GO :0045927 59 29.90 1654 1.97 2.32E-06
positive regulation of growth rate GO :0040010 54 26.27 1453 2.06 2.38E-06
regulation of growth rate GO :0040009 54 26.31 1455 2.05 2.38E-06
cellular localization GO :0051641 26 7.85 434 3.31 2.38E-06
reproduction GO :0000003 80 48.00 2655 1.67 3.76E-06
*Analysis performed using Web-Based Gene Set Analysis Toolkit (WebGestalt).
**Statistical method: Hypergeometric; p-value adjusted using the Benjamini-Hochberg multiple test adjustment.
doi:10.1371/journal.pntd.0004929.t003
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the distribution of the most enriched GO terms at 100 nM IVM exposure for 48 h, for which
reproductive processes (reproduction, embryo development and larval development) were sta-
tistically overrepresented in the dataset. RNAi phenotypes which were significantly overrepre-
sented in the down-regulated genes dataset compared with their overall abundance in the C.
elegans RNAi phenotype dataset in Wormbase are shown in Fig 2 and S4 Table (FDR< 0.05;
hypergeometric test). The most commonly observed RNAi phenotype is “embryonic lethal”.
Over 81% of down-regulated genes involved in reproduction were associated with an embry-
onic lethal RNAi phenotype, while 62% were linked to a larval arrest phenotype. At the 24 h
time point, no significantly enriched biological processes or molecular functions were noted.
“Cytoskeleton” was the greatest enriched cell component term (GO:0005856; FDR = 0.007).
Study 2: Exposure to higher IVM concentrations. In the second study, most changes
occurred after 48 h exposure to 300 nM IVM, and only after 5 days when exposed to 1 μM. The
expression of 535 genes was dysregulated across several time points and/or concentrations (S1
Table). As the BCVs varied with time and across concentrations, resulting in higher FDRs (as
BCVs increased), it was difficult to see a concentration-dependent trend across the DE genes
detected in the study and therefore the overlap between DE genes across concentrations and
time points was very limited.
At 48 h, only 3 genes overlapped between the groups exposed to 300 nM and 1 μM IVM; at
5 days, 18 genes overlapped between both treatment groups. Among them, 3 genes encoding
Fig 2. Top RNAi phenotypes enriched in reproductive processes after 48 h exposure to 100 nM IVM. The listed
enriched phenotypes obtained were based on Gene Ontology analysis ofC. elegans orthologs of DE genes. These
phenotypes were significantly overrepresented compared with their overall abundance in theC. elegansRNAi phenotype
dataset in Wormbase. Statistical method: Hypergeometric; p-value adjusted using the Benjamini-Hochberg multiple test
adjustment (FDR<0.05).
doi:10.1371/journal.pntd.0004929.g002
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cuticle collagens (Bm8043, Bm4605, and Bm11024; log2 fold-changes -0.84–-2.23), and others,
to cite a few only, coding for a major facilitator superfamily protein (Bm6076; log2 fold-changes
-1.1 and -2.21), Bma-zyg-9 (Bm3504; log2 fold-change -1.51 at 48 h and -1.20 at 5 days), which
may play a role in meiosis, were down-regulated. Upregulated across concentrations at 5 days
was a serpin precursor (Bm9380; log2 fold-changes 1.37 and 2.08).
Transcriptomic profiles of worms exposed to 300 nM IVM. Worms incubated at this
concentration showed the largest change after 48 h exposure (132 DE genes). 89% of DE genes
were down-regulated at this time. The most strongly down-regulated gene encodes a prominin
protein (Bm3187; log2 fold-change: -3.84) predicted to be a 5-transmembrane domain glycopro-
tein. Other annotated genes of potential interest that were highly down-regulated include IQ
calmodulin-binding motif family protein (Bm2777; log2 fold-change: -2.01), Fanconi anemia
complementation group D2 protein (Bm6522; log2 fold-change: -2.0), CG7507-PA (Bm5897;
log2 fold-change: -1.20), an ortholog of dynein heavy chain-1 in C. elegans, and nucleoporins
(Bm6397 and Bm5288; log2 fold-change: -1.19 and -1.91, respectively). The most up-regulated
gene was Bm12387 (log2 fold-change: 3.83), annotated as a hypothetical protein. Gene Ontology
analysis at this time point showed an enrichment of genes related to “establishment of meiotic
spindle orientation” (GO:0051296; FDR = 0.04), “meiotic spindle organization” (GO:0000212;
FDR = 0.04) and “establishment of meiotic spindle localization” (GO:0051295; FDR = 0.04) (S2A
Table).
By 5 days, the number of DE genes decreased from 132 to 68. Bm11304, a KH domain con-
taining protein, was the most prominently down-regulated gene at this time point and concen-
tration (log2 fold-change: -5.9), while Bm1543, a lectin C-type domain containing protein, was
the most up-regulated (log2 fold-change: 5.88). GO enrichment analysis revealed enrichment
of genes in molecular processes related to “fatty-acyl-CoA binding” (GO:0000062;
FDR = 0.0057), “structural constituent of cuticle” (GO:0042302; FDR = 0.0002), and “structural
molecule activity” (GO:0005198; FDR = 0.016) (S2C Table).
Transcriptomic profiles of worms exposed to 1 μM IVM. Exposure to 1 μM IVM resulted
in the dysregulation of 147 genes at 48 h and 271 after 5 days. Most strongly down-regulated at
48 h was Bm2880, a tachykinin-like peptide receptor protein (log2 fold-change: -5.51), and a
GRIP-domain containing protein, at 5 days (log2 fold-change: -5.71). At both time points, two
hypothetical proteins were maximally up-regulated (log2 fold-change: 6.76 and 6.13, respec-
tively). Transcriptomic data from worms exposed to 1 μM IVM for 48 h showed “translation” to
be the most significantly enriched GO term (GO:0006412; FDR = 8.87e-06) (S2B Table). After
5 days exposure, down-regulation of a phospholipase C homolog (Bm3716; log2 fold-change:
-1.54), and of 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta 4 (Bm1768; log2
fold-change: -0.89) was observed. Significantly enriched GO terms also included terms related to
“double-strand break repair via nonhomologous end joining” (GO:0006303; FDR = 0.02), “cyto-
kinesis” (GO:0007109; FDR = 0.02), “cytokinetic cell separation” (GO:0000920; FDR = 0.02),
“cytokinetic process” (GO:0032506; FDR = 0.003), “cytokinesis after meiosis” (GO:0033206;
FDR = 0.01) and “polar body extrusion after meiotic divisions” (GO:0040038; FDR = 0.004).
Nine genes were also found enriched in the “collagen and cuticulin-based cuticle development”
(GO:0040002; FDR = 0.003) category (S2D Table).
Discussion
We performed time-series studies to assess the effects of exposure to different concentrations
of IVM on adult B.malayi females in vitro at the transcriptomic level. Of particular interest
was the identification of DE genes involved in reproduction, which could help explain the ster-
ilizing effect of IVM on adult filariae.
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Overall BCVs were calculated between samples in both drug studies and were 17–27% in
the first study and 15–35% in the second study (S3 Table, S1 Fig), suggesting acceptable biolog-
ical variability among replicates. Typically, BCVs for datasets from well-controlled studies
range from 10% (genetically identical model organisms) to 40% (human data). In a previous
study, we reported BCVs to be 14–25% for samples of adult female worms immediately upon
extraction from jirds [20]. However, BCVs were slightly higher at the 48 h time point in study
2 (30 and 35%). As BCVs varied across the different concentrations and time points and
resulted in higher FDRs as the BCVs increased, we were unable to see obvious trends in con-
centration- dependence and detected few DE genes that overlapped across the different com-
parisons. Therefore, our discussion is mainly centered on the analysis of the DE genes detected
for each pairwise comparison. We focus on a few processes particularly affected by exposure to
IVM in vitro.
IVM significantly reduces the release of mf after 24 h exposure to IVM in vitro and by 4
days, mf output ceases completely at concentrations 0.15 μg/ml [15]. In the present work, we
exposed adult females at a concentration of 100 nM (0.09 μg/ml) for up to 72 h in the first
study and 300 nM (0.267 μg/ml) and 1 μM (0.89 μg/ml) for up to 5 days in the second study.
Although we did not measure mf output, we suspect that adult females were sterilized at these
concentrations based on the previous work. In addition, wsp (Wolbachia surface protein)
expression has been shown to decrease significantly with IVM concentrations>0.31 μg/ml
(348 nM) [15]. It is therefore possible that some of the observed changes in gene expression
might be related to changes inWolbachia densities; however, we are unable to confirm this as
wsp expression was not measured.Wolbachia-related death at these concentrations could have
negative implications on reproduction, molting and survival. Interestingly, theWolbachia sur-
face protein wBm0432 has been shown to interact with several key enzymes involved in the
host glycolytic pathway, including aldolase and enolase, and wBm0152 interacts with the host
cytoskeletal proteins actin and tubulin [37]. These interactions could have an effect on growth
and embryogenesis, effects we observed at the transcriptome level.
IVM dysregulates genes involved in meiosis and calcium signaling
surrounding fertilization
Dyneins and kinesins play important roles in mitosis and meiosis [38–40] and both were differ-
entially expressed by exposure to IVM. CG7507-PA (Bm5897), orthologous to dynein heavy
chain-1 in C. elegans, was down-regulated after IVM exposure. These molecular motors use
ATP to move along microtubules and function in carrying cargo such as vesicles and organelles
which are too large to diffuse to other cellular destinations [41]. In C. elegans, dynein is associ-
ated with nuclear envelopes, centrosomes and meiotic and mitotic spindle poles [42]. Kinesin-
1 and cytoplasmic dynein function together to move the meiotic spindle to the oocyte cortex
[39]. During anaphase, the meiotic spindle is attached to the cortex by one pole, allowing selec-
tive disposal of half the chromosomes in a polar body [39]. In C. elegans, dynein light chain 1
(dylt-1) is expressed in adult body wall muscle, larval and adult pharynx, posterior intestine
and nervous system and is required for normal embryonic and larval viability. The GO term
“establishment of meiotic spindle orientation” was enriched in this study. One gene associated
with this term was Bm2777 (IQ calmodulin-binding motif family protein), a homolog of aspm-
1 in C. elegans and mammalian ASPM (Abnormal Spindles & Primary Microcephaly) [43].
ASPM-1 is required for oocyte meiotic spindle pole assembly and is essential for the meiotic
spindles to align orthogonally and in close proximity to the overlying plasma membrane [43].
Another gene that may play a role in meiosis is Bma-zyg-9 (Bm3504), which was down-regu-
lated at the two highest IVM concentrations. In C. elegans, ZYG-9 acts to ensure correct
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microtubule assembly throughout the cell cycle of early embryos during mitosis, interphase
and meiosis [44–46].
A major facilitator superfamily protein (Bm6076), down-regulated at 5 days at the two high-
est IVM concentrations, is highly expressed in the digestive tract of B.malayi [47]. In C. ele-
gans, RNAi phenotypes associated with the ortholog of Bm6076 include “embryonic lethal”,
“asymmetric cell division defective early embryo”, and “spindle pole pulling force variant”,
indicating that this gene is probably important for embryo development.
Calcium signaling plays a crucial role in reproduction and fertilization and has been exten-
sively studied in C. elegans [48]. During meiotic maturation of the oocyte, calcium signaling is
linked to inositol 1,4,5-triphosphate receptor (ITR-1), N-methyl D-aspartate type glutamate
receptor subunit (NMR-1) and UNC-43, which encodes a type II calcium/calmodulin-depen-
dent protein kinase [49]. Phospholipase C catalyzes the hydrolysis of phosphatidylinositol
4,5-bisphosphate (PIP2) into diacylglycerol (DAG) and inositol (1,4,5) triphosphate (IP3) [50].
IP3 binds receptors on the endoplasmic reticulum to mobilize Ca
2+ into the cytosol. We
observed down-regulation of a phospholipase C homolog (Bm3716) and of 1-phosphatidylino-
sitol-4,5-bisphosphate phosphodiesterase beta 4 (Bm1768). The latter is an ortholog of egl-8
(egg-laying defective) and is predicted to have phosphatidylinositol phospholipase C activity
and Ca2+ ion binding activity. Interestingly, EGL-8 also plays a role in regulating the release of
acetylcholine from motor neurons, thus affecting locomotion, and is expressed in all neurons
in C. elegans [51]. One of the most down-regulated DE genes we observed was inositol-1
(Bm11145), which is required for the biosynthesis of phosphatidylinositol [52]. Cumulatively,
down-regulation of these genes suggests that Ca2+ signaling (via IP3) may be affected following
exposure to IVM, with adverse effects on ovulation.
IVM selection on β-tubulin has been reported in O. volvulus and H. contortus; IVM selec-
tion changes the frequency of β-tubulin alleles [53]. Microtubules, which are assembled from
heterodimers of α- and β-tubulin, drive chromosome motion in mitosis and meiosis [54], and
so IVM selection for β-tubulin changes could have downstream effects on meiosis. A recent
study in H. contortus has also shown that IVM binds to and alter the tubulin polymerization
equilibrium, which can lead to mitotic arrest [55].
A number of other genes that function in fertilization were dysregulated by IVM exposure.
Bma-emo-1 (Bm14080), which is involved in ovulation, intracellular protein transport and
oocyte growth in C. elegans, was down-regulated. C. elegans emo-1mutants fail to ovulate after
meiotic maturation and oocytes remain trapped in the gonad arm and become endomitotic
[56]. Fanconi anemia complementation group D2 protein (Bm6522) was decreased following
IVM treatment; deletion of the C. elegans ortholog results in egg-laying defects, precocious
oogenesis, and partial defects in fertilization, and may play a role in double-stranded DNA
break repair during embryogenesis [57].
IVM exposure dysregulates the expression of genes involved in embryo
development
IVM exposure downregulated the expression of several genes involved in RNA transport, with
consequences on embryo development. Nuclear pore complexes (NPCs) are highly conserved
proteinaceous structures embedded in the nuclear envelope that provide a connection between
the nucleus and the cytoplasm [63]. Several genes (Bm6397, Bm9537, Bm5288) orthologous to
NPC proteins in C. elegans (npp-13, npp-14 and npp-21 respectively) were down-regulated.
Nucleoporins comprise NPCs and may function in transcriptional events, mRNA export, and
genome organization [58]. In the nucleoplasm, dynamic nucleoporins may be functioning in
the activation of developmental genes [58]. A subclass of nucleoporins plays a role in orienting
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the mitotic spindle in C. elegans embryos, and RNAi depletion of any of these nucleoporins
leads to spindle orientation defects [64]. One of these nucleoporins is NPP-13. NPP-21, an
ortholog of human TPR (translocated promoter region), is also involved in embryo develop-
ment, locomotion and nematode larval development; RNAi knockdown results in embryonic
lethal, larval arrest and locomotion variant phenotypes [59]. No obvious RNAi phenotypes
have been reported for NPP-14.
Lastly, we observed down-regulation of Bm5608, which is orthologous tomel-46 (maternal
effect lethal). In C. elegans, this gene encodes a DEAD-box protein required in the germ line
for proper oogenesis and zygotically for post-embryonic development [60].
Pharyngeal pumping
Interestingly, we saw a significant down-regulation of Bma-nep-1 (Bm7419), which has 45.8%
identity to nep-1 in C. elegans. Neprilysins are transmembrane zinc-metalloproteases that have
roles in cell-to-cell signaling [61]. The expression pattern of nep-1 in C. elegans is limited to
pharyngeal cells and a single head neuron; it is an effector of locomotion and pharyngeal
pumping [62]. The locomotion of nep-1 knockouts is significantly impaired and RNAi knock-
down results in a maternal sterile phenotype [62].
Oxidative phosphorylation
We noted a significant enrichment of dysregulated genes involved in oxidative phosphoryla-
tion (100 nM, 48 h). Expression of ubiquinol-cytochrome C reductase (Bm6047), succinate
dehydrogenase (Bm3783), ATP synthase epsilon chain (Bm3758), ATP synthase f chain
(Bm5403), NADH dehydrogenase subunit 1 (Bm10539) and cytochrome b5-like heme/steroid
binding domain containing protein (Bm2497) was down-regulated. In contrast, NADH dehy-
drogenase subunit 1 was up-regulated at 1 μM (48 h). The down-regulation of these genes may
suggest that ATP synthesis is directly or indirectly inhibited by IVM. Abamectin (ABA),
another ML in the avermectin family, caused concentration-dependent (5–25 μM) inhibition
of the respiratory chain [63]. Reduced expression of ribosomal proteins, histones, and prosapo-
sins [64] are a signature of oxidative stress in C. elegans, but the homologs of these genes were
not DE or only marginally so in our study. In nematodes, ATP is obtained by glycolysis or oxi-
dative phosphorylation, using a variety of substrates [65, 66]. Several anthelmintics have been
proposed to target helminth oxidative phosphorylation enzymes [67].
Glutamate-gated chloride channels
IVM binding to GluCls induces a slow onset, pseudo-irreversible glutamate-gated current [10,
68, 69]. Given the nature of the drug-receptor association, one can speculate on the necessity
for a new cohort of GluCls to be expressed to overcome the effects of IVM. Little is known
about the rate of receptor turn-over and synthesis in adult parasitic nematodes, but this sce-
nario could contribute to the prolonged sterilization of adult filariae observed after a single
dose of IVM. In this context, it might have been expected that this drug-receptor interaction
would lead to increased expression of GluCl genes, which was not observed; expression of the
putative receptor for IVM, Bm-avr-14 (Bm1710 isoforms) [10], was not dysregulated following
exposure to the drug. GluCl-encoding genes are abundantly expressed in B.malayi female
reproductive tissue (among other body parts, such as the pharynx), suggesting that the steriliz-
ing effects of IVMmay occur at a very early embryonic stage [14]. In males, GluCl expression
in reproductive tissues was less abundant, but was localized to some extent to somatic muscle
and the vas deferens, likely controlling body movement as well as sperm cell development and
release [14]. Using a high-level IVM-resistant C. elegans strain (the strain DA1316, which has
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null mutations in three GluCl subunits: avr-14; avr-15; glc-1) [70], no differential expression
was noted in the genes encoding the GluCl subunits avr-14 or avr-15, whereas a log fold-
change of 0.78 (FDR = 0.06) in glc-1 was observed following treatment with 1.1 μM IVM. Expo-
sure to the drug impaired pharyngeal pumping to some extent in that strain. The authors con-
cluded that IVM induced differential expression of several genes in response to food
deprivation, which are likely unrelated to GluCl expression [70].
Effects of in vitro culture on the B.malayi transcriptome
Twenty-nine cuticle collagen genes showed differential expression across both studies, of
which 17 were significantly down-regulated following exposure to IVM. Previously, we exam-
ined the effect of in vitro cultivation, without anthelmintic, on the transcriptome of B.malayi
and found 21 cuticle collagen genes to be significantly DE over time [20]. Thirteen of the DE
collagen genes detected in the current work overlapped with dysregulated genes from the previ-
ous study (Bm11024, Bm11095, Bm11338, Bm1249, Bm2110, Bm2605, Bm2854, Bm4605,
Bm7408, Bm7894, Bm8043, Bm8439 and Bm9021). Bm11024 and Bm11095 were significantly
down-regulated in the in vitro cultivation study at 48 h in culture, yet in the present work, we
found these genes to be up-regulated at 300 nM IVM for 5 days. Collagen gene dysregulation
likely represents a non-specific marker of stress [20, 64]. Scanning electron microscopy has
shown that IVM exposure leads to damage of the surface of B.malayi third-stage larvae, induc-
ing the loss of regular cuticular annulations and causing morphological changes in the cuticular
surface in the head, body, and tail regions [71]. Previously, we observed the pronounced up-
regulation of a serpin precursor (Bm9380), and of a hypothetical protein (Bm337), attributed
to in vitro cultivation [20]. In the current study, both genes were up-regulated, but to a much
lower extent. This suggests that our untreated control corrects, to some extent, for differential
gene expression solely due to life in liquid culture media.
Comparison of the IVM transcriptional response in C. elegans to B.
malayi
We compared the IVM transcriptional response in C. elegans to B.malayi to look for common
GluCl-independent, IVM-dependent gene expression signatures. The transcriptional response
to IVM in C. elegans using whole genome microarray led to the identification of genes involved
in early food deprivation response (i.e., fat mobilization) [70]. Using the DA1316 mutant strain
(null mutations in three GluCl subunits), which is resistant to the paralytic effects of IVM on
the body wall, worms were exposed to 100 nM or 1.1 μM IVM for 4 h. This resulted in the up-
regulation of 3 genes and down-regulation of 12 genes in the 100 nM IVM group, with 216 up-
regulated and 153 down-regulated in the 1.1 μM group. Comparing our dataset with the C. ele-
gans study showed that only 5 genes overlapped, of which 2 were significantly down-regulated
in both studies: 6-pyruvoyl tetrahydropterin synthase (Bm1701) and cytochrome b5-like
heme/steroid binding domain containing protein (Bm2497).
Conclusion
We have shown that IVM exposure alters the expression of genes that are likely to function in
the B.malayi female reproductive system. Through several biological pathways, genes involved
in meiosis were particularly affected. These findings provide some insight into the mechanisms
involved in IVM-induced reduction in mf output and impaired fertility, embryogenesis, and
larval development and the transcriptomic dataset provides important experimental avenues to
pursue the mechanism by which IVM sterilizes worms. This is also the first report of IVM
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exposure having an effect on oxidative phosphorylation at the transcript level, a metabolic
pathway believed to be vital for nematodes.
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